1 1

GeneBio Systems

Recombinant FGL1 Monoclonal Antibody

Recombinant FGL1 Monoclonal Antibody

AN301921L

£302.00 GBP
£302.00 GBP
Sale Sold out
Shipping calculated at checkout.

Size::50μL

Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Monoclonal Antibodies;Recombinant Antibodies

Abbreviation:FGL1

Target Synonym:FGL;Fibrinogen-like protein;Liver fibrinogen-related protein;LFIRE;HP-041;Hepassocin;HPS;HFREP-1;LFIRE-1;HFREP1;Fibrinogen-like protein 1;Liver fibrinogen-related protein 1;FGL1;Fgl1;Hepassocin;HFREP1;HFREP-1;FGL 1;Fibrinogen like 1;Fibrinogen like protein 1;Fibrinogen related protein 1;Hepatocellular carcinoma related sequence;Hepatocyte derived fibrinogen related protein 1;Hepatocyte-derived fibrinogen-related protein 1;HFREP 1;HP 041;HP041;LFIRE 1;LFIRE1;Liver fibrinogen related protein 1;MFIRE 1;MGC108569;MGC12455;MGC37822;OTTHUMP00000122468

Research Areas:Cardiovascular

Conjugation:Unconjugated

Host:Rabbit

Species reactivity:Human;

Application:WB;IHC

Isotype:IgG,κ

Clonality:Monoclonal;Recombinant

Clone NO.:A637

UNIProt ID:Q08830

Accession:

Background:Fibrinogen-like protein 1 (FGL1), also known as hepassocin, is a secreted protein mainly expressed in liver and its expression is further enhanced following acute liver injury. FGL1 null mice have multiple metabolic abnormalities and are more prone to develop hepatocellular carcinoma under certain experimental conditions, suggesting FGL1 has diverse functions in vivo. More recently, FGL1 was found to be highly expressed in human cancer cells and function as an inhibitory ligand for LAG3. Blockade of the FGL1-LAG3 interaction stimulates tumor immunity in mouse models. In addition, a high plasma FGL1 level in human cancer patients is associated with a poor prognosis and resistance to anti-PD-1/PD-L1 immunotherapy.

Concentration:1 mg/mL

Immunogen:Recombinant human FGL1 fragment

Buffer:PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.

Purification method:Protein A purified

Dilution:WB 1:1000;IHC 1:50-1:200

Calculated MW:36 kDa

ObservedMW:34 kDa

View full details